Literature DB >> 6384564

Noninvasive carotid artery evaluation following endarterectomy.

L L Gonzalez, L Partusch, P Wirth.   

Abstract

There has been recent interest in carotid restenosis following endarterectomy. To evaluate the significance of this complication, 2549 consecutive patients who were evaluated for suspected carotid artery occlusive disease by carotid phonoangiography, ocular plethysmography, and B-mode scanning techniques over a 21-month period were reviewed. Within this group a total of 155 patients had previously undergone a carotid endarterectomy. Of these, only four patients manifested clinically significant restenosis. In the majority of patients the carotid bifurcation was free of significant disease. The "carotid shelf" that represents the superior aspect of residual intimal plaque following endarterectomy could be clearly identified in the early postoperative period; however, it later blended to become less distinct. In a few instances, however, the amount of residual plaque at the lower extent of the endarterectomy was very prominent and remained so during follow-up studies, suggesting the possibility that this might represent a focus for future thrombosis. We conclude that noninvasive testing as used herein is an accurate method of assessing the carotid artery following endarterectomy. The accuracy of these techniques has been of such high degree that 16 carefully selected patients have subsequently undergone carotid endarterectomy without preoperative angiography.

Entities:  

Mesh:

Year:  1984        PMID: 6384564

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  2 in total

1.  The geometry and mechanics of saphenous vein patch angioplasty after carotid endarterectomy.

Authors:  J P Archie
Journal:  Tex Heart Inst J       Date:  1987-12

2.  Recurrent versus residual carotid stenosis. Incidence detected by Doppler ultrasound.

Authors:  R W Barnes; M L Nix; J P Wingo; B T Nichols
Journal:  Ann Surg       Date:  1986-06       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.